Every SEC Form 3/4/5 on record for this filer (CIK 1365619) — 7 issuers, 51 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | Director | 2019-07-17 → 2026-06-17 | 11 | −$1M |
| EWTX | Edgewise Therapeutics, Inc. | Director | 2021-03-25 → 2026-06-17 | 6 | — |
| PCRX | Pacira BioSciences, Inc. | Director | 2016-06-08 → 2026-06-12 | 17 | −$1M |
| ACAD | ACADIA PHARMACEUTICALS INC | Director | 2016-06-10 → 2026-06-01 | 17 | −$2M |
| PTLA | PORTOLA PHARMACEUTICALS INC | Director · lapsed | 2016-06-20 → 2020-07-02 | 6 | — |
| DVAX | DYNAVAX TECHNOLOGIES CORP | Director · lapsed | 2015-10-14 → 2019-05-31 | 5 | — |
| PETX | ARATANA THERAPEUTICS, INC. | Director · lapsed | 2016-06-28 → 2018-07-30 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| MIRM | 2025-09-11 | Sell | 15,509 | $74.34 | $1M | 17,194 |
| MIRM | 2025-09-11 | Sell | 1,491 | $75.07 | $111,929 | 15,703 |
| ACAD | 2025-06-04 | Sell | 14,446 | $21.78 | $314,634 | 15,095 |
| PCRX | 2024-08-16 | Buy | 1,000 | $12.81 | $12,810 | 17,552 |
4 of 7 issuers are covered and open a security page; the rest are on file here only.
